Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P. -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (740)	6/22/1999 11:08:00 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 4974

Hopping, hopping, hopping, hopping...... the sector is hopping. Very glad to see Alza go to a weak company. Leaves leveraged business plans for those companies with momentum. Abbott..... sort of like Ortho..... give them money, stand back, and listen for the flush. Good deal for both companies, but it won't create anything special, and Abbott itself will just be future fodder.

To: LLCF who wrote (740)	6/22/1999 11:11:00 AM
From: aknahow	Read Replies (1) \| Respond to of 4974

AZA?????? No wonder we don't understand one another. I don't see the target buying its' stock either. I thought I have been posting about the acquiring party, which in this case would be Abbot Labs , not AZA/Alza. Sorry, probably those damn comas, my spelling and sentence structure. Do insiders and their friends of a target company sometimes buy ahead of news of a bid. Sure and they often get caught by the S.E.C. too. Just commenting. Realize you were not talking about insiders but the target company itself.